Marker Therapeutics, Inc.
MRKR· Nasdaq
MRKRMarker Therapeutics, Inc.
Filed Aug 15, 2016 · 10-Q · 46 days after period end · 0001193125-16-682054
| Metric | Q2 2016 | Q2 2015 | Q2 2014 | Q2 2013 |
|---|---|---|---|---|
| Net Income | $5.97M | -$60.22M | $753.48K | -$870.81K |
| EPS Diluted | $0.35 | -$1.80 | $0.05 | -$0.87 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Marker Therapeutics, Inc. · CIK 1094038 · Engraved from SEC EDGAR
ended Jun 30, 2016 · filed Aug 15, 2016 · 46 d after period end
